|
David Stievater joined PDI in November 2006 as Senior Vice President of Emerging Pharma. Mr. Stievater comes to PDI from ImpactRx Inc. a provider of proprietary physician data for measuring pharmaceutical promotional effectiveness. At ImpactRx Mr. Stievater served as V.P. Sales and V.P. Business Development and was a member of the executive team. He led the sales organization through a period of rapid expansion more than doubling revenue and significantly expanding their customer base. Prior to ImpactRx Mr. Stievater spent several years providing consulting services including marketing decision support to the biopharmaceutical industry and concluded an eleven-year tenure with the Monitor Company Group L.P. as Partner and Global Account Manager. He has advised pharmaceutical clients on such issues as sales force strategy and multi-channel physician marketing. Mr. Stievater began his career as a financial analyst at Merrill Lynch & Co. He earned his Masters in Business Administration from the University of Michigan and a Bachelor of Science degree from Georgetown University. | 